BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2019
View Archived Issues
BLU-5937: P2X3 homotrimeric receptor antagonist with improved taste safety profile for cough
Read More
Long-term data presented from FORWARD-2 study of ALKS-5461
Read More
NRD.E1 demonstrates promising safety and efficacy in proof-of-concept study
Read More
Results from first portion of phase I study of PRN-1371 in patients with solid tumors
Read More
Location, location, location: Looking between the lines leads to neurofibromatosis insight
Read More
A novel antagonistic CD73 antibody for cancer immunotherapy presented
Read More
Fruit fly avatars identify drug sensitivity
Read More
Flu virus makes bacteria stick around
Read More
NI-956, a new prodrug inhibitor of aminopeptidase A, shows promise for hypertension treatment
Read More
Discovery of a broad-spectrum human antibody to influenza A recognizing a new site of vulnerability
Read More
FDA approves Zolgensma for spinal muscular atrophy
Read More
MIDRIXneo, a personalized vaccine as adjuvant therapy for immune checkpoint blockade
Read More
Jakafi approved by FDA for steroid-refractory acute GvHD
Read More
Aclaris Therapeutics patents JAK1 and JAK3 inhibitors
Read More
ORIC Pharmaceuticals presents CD73 inhibitors
Read More
FDA approves Piqray for HR+/HER2-, PIK3CA-mutated advanced breast cancer
Read More
Zealand Pharma describes amylin and/or calcitonin receptor agonists
Read More
Nanjing CART Medical Technologies discloses CAR T cells for hematologic cancer
Read More
Alpine Immune Sciences divulges new fusion proteins
Read More
Sensorion signs hearing loss research partnership framework agreement with Institut Pasteur
Read More
PCI Biotech begins pivotal RELEASE study of fimaChem in inoperable bile duct cancer
Read More
Phase III study of Lyrica in PGTC seizures fails to meet primary endpoint
Read More
Genmab initiates phase I/IIa safety study of GEN-1046 in malignant solid tumors
Read More
OnKure begins new phase I trial of OKI-179 in solid tumors
Read More